Literature DB >> 12461613

CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri.

Peter J Barth1, Annette Ramaswamy, Roland Moll.   

Abstract

CD34(+) fibrocytes are widely distributed in normal connective tissues but have been reported to be absent within the stroma associated with invasive carcinomas. In the present study we investigated the presence and distribution of CD34(+) fibrocytes and alpha-smooth muscle actin (alpha-SMA) positive myofibroblasts in cervical intraepithelial neoplasia III (CIN III; n=8), invasive carcinoma of the cervix ( n=18) and adjacent normal cervical stroma. Normal cervical stroma and the stroma adjacent to CIN III disclosed a dense network of CD34(+) fibrocytes, whereas the stroma of invasive carcinoma was virtually free of this cell population. Early stromal invasion by squamous carcinoma was characterized by a focal loss of CD34(+) fibrocytes. alpha-SMA-positive myofibroblasts were not seen in the normal cervical stroma but occurred in six of eight cases of CIN III adjacent to the atypical epithelium. The stroma of invasive carcinoma was made up of large amounts of haphazardly arranged alpha-SMA-positive myofibroblasts. In the setting of the present study, a loss of CD34(+) fibrocytes was specific for stromal alterations associated with invasive carcinoma and proved to be a sensitive tool in detecting small foci of stromal invasion. Therefore, detection of a loss of CD34(+) fibrocytes may constitute an adjunctive tool in detecting (1) early stromal invasion and (2) invasive carcinoma in small biopsy specimens. Moreover, the present study shows that CD34(+) fibrocytes and myofibroblasts play an important role in stromal remodeling associated with invasive squamous cell carcinoma of the cervix.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461613     DOI: 10.1007/s00428-002-0713-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  22 in total

1.  Stromal expression of CD34, α-smooth muscle actin and CD26/DPPIV in squamous cell carcinoma of the skin: a comparative immunohistochemical study.

Authors:  Ayper Kacar; Ata Türker Arikok; Tuba Dilay Kokenek Unal; Evrim Onder; Sema Hucumenoglu; Murat Alper
Journal:  Pathol Oncol Res       Date:  2011-06-15       Impact factor: 3.201

2.  CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder.

Authors:  Wilhelm Nimphius; Roland Moll; Peter Olbert; Annette Ramaswamy; Peter J Barth
Journal:  Virchows Arch       Date:  2007-02       Impact factor: 4.064

3.  Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast.

Authors:  Peter J Barth; Roland Moll; Annette Ramaswamy
Journal:  Virchows Arch       Date:  2005-04-19       Impact factor: 4.064

Review 4.  The role of circulating fibrocytes in fibrosis.

Authors:  Timothy E Quan; Shawn E Cowper; Richard Bucala
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 5.  Fibrocytes in the Tumor Microenvironment.

Authors:  David Roife; Jason B Fleming; Richard H Gomer
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Adenoid basal carcinoma arising in the cervical polyp: an immunohistochemical study of stromal cells.

Authors:  Naoto Kuroda; Kohki Hirano; Masahiko Ohara; Takashi Hirouchi; Keiko Mizuno; Ayumi Kubo; Hideaki Enzan
Journal:  Med Mol Morphol       Date:  2007-06-18       Impact factor: 2.309

7.  CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin.

Authors:  Cordula Wessel; Christina C Westhoff; Katharina Nowak; Ingrid Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2008-09-24       Impact factor: 4.064

8.  Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2.

Authors:  Hendrik W van Deventer; Daniela A Palmieri; Qing Ping Wu; Everett C McCook; Jonathan S Serody
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

9.  CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.

Authors:  Annette Ramaswamy; Roland Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2003-07-29       Impact factor: 4.064

Review 10.  Mesenchymal stem cells as vectors for lung disease.

Authors:  Michael R Loebinger; Elizabeth K Sage; Sam M Janes
Journal:  Proc Am Thorac Soc       Date:  2008-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.